Current Studies

Acute HIV Studies at UNC

CID 0804 Longitudinal (CTRC 2134) - Acute HIV Longitudinal Study

  • Population: Individuals diagnosed with Acute HIV Infection
  • Contact: Amanda Crooks 919-843-9564 or 919-428-7612

Status: On-going / Recruiting

PHI 04 (IRB# 12-1274)- QD Therapy with STRIBILD for Acute HIV Infection

  • Question: Treatment of Acute HIV infection with one tablet once a day
  • Population: Acute HIV infection
  • Medication: STRIBILD (fixed-dose combination elvitegravir, cobicistat, emtricitabine, and tenofovir)
  • Duration: 96 weeks (medication provided for the first 48 weeks)
  • Contact: Blair Turner, NP 919-966-7747
  • Substudies: leukapheresis, colonoscopy w/ biopsy (compensation provided)

Status: On-going / No longer recruiting

PHI 05 - QD Therapy with Dolutegravir/Epzicom for Acute HIV Infection

  • Question: Treatment of Acute HIV infection with one tablet once a day
  • Population: Acute HIV infection
  • Medication: Fixed-dose combination of dolutegravir and epzicom
  • Duration: 2 years (medication provided throughout)
  • Contact: Blair Turner, NP 919-966-7747

Status: On-going / Recruiting